Ray Dalio Moderna, Inc. Transaction History

Bridgewater Associates, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $1.55 Million - $2.55 Million	15,309 New	15,309 $1.82 Million
Q2 2023 Aug 11, 2023	BUY	$118.5 - $160.53 $3.02 Million - $4.09 Million	25,489 Added 474.13%	30,865 $3.75 Million
Q1 2023 May 12, 2023	SELL	$135.66 - $197.02 $312,153 - $453,343	-2,301 Reduced 29.97%	5,376 $825,000
Q4 2022 Feb 13, 2023	SELL	$118.38 - $210.04 $1.16 Million - $2.05 Million	-9,758 Reduced 55.97%	7,677 $1.38 Million
Q3 2022 Nov 10, 2022	SELL	$118.07 - $194.18 $27.4 Million - $45 Million	-231,722 Reduced 93.0%	17,435 $2.06 Million
Q2 2022 Aug 11, 2022	BUY	$117.13 - $176.59 $23.7 Million - $35.8 Million	202,476 Added 433.74%	249,157 $35.6 Million
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $5.44 Million - $10.1 Million	43,042 Added 1182.8%	46,681 $8.04 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $1.05 Million - $1.72 Million	-4,670 Reduced 56.2%	3,639 $924,000
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $1.84 Million - $4.03 Million	8,309 New	8,309 $3.2 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.